International Journal of Trichology

EDITORIAL
Year
: 2021  |  Volume : 13  |  Issue : 6  |  Page : 1--3

“Let food be thy medicine”: Value of nutritional treatment for hair loss


Ralph M Trueb 
 Center for Dermatology and Hair Diseases, Wallisellen, Zurich, Switzerland

Correspondence Address:
Ralph M Trueb
Center for Dermatology and Hair Diseases, Wallisellen, Zurich
Switzerland




How to cite this article:
Trueb RM. “Let food be thy medicine”: Value of nutritional treatment for hair loss.Int J Trichol 2021;13:1-3


How to cite this URL:
Trueb RM. “Let food be thy medicine”: Value of nutritional treatment for hair loss. Int J Trichol [serial online] 2021 [cited 2021 Dec 5 ];13:1-3
Available from: https://www.ijtrichology.com/text.asp?2021/13/6/1/330775


Full Text



“Let food be thy medicine and medicine be thy food” is a proverb originally attributed to Hippocrates, the father of medicine. Hippocrates was among the first to establish the role of diet in health and disease. He proposed lifestyle modifications, including dietary factors, to prevent or treat diseases, and yet, there is hardly another field with so much prejudice, misconception, and debate as diet and health, let alone hair health. In his publication, “How Doctors Think,” Jerome Groopman from Harvard Medical School focuses on the thinking errors in medicine and among them succinctly states that “Aside from relatively common dietary deficiencies – lack of Vitamin B12 causing pernicious anemia, or insufficient Vitamin C giving rise to scurvy – little is known about the effects of nutrition on many bodily functions.”[1]

The fact is that quantity and quality of hair are closely related to the nutritional state of an individual. Normal supply, uptake, and transport of proteins, calories, trace elements, and vitamins are of fundamental importance in tissues with a high biosynthetic activity such as the hair follicle. Because hair shaft is composed almost entirely of protein, namely, keratin, the protein component of diet is critical for the production of normal healthy hair. The rate of mitosis is sensitive to the calorific value of the diet, provided mainly by carbohydrates. Finally, a sufficient supply of vitamins and trace metals is essential for the biosynthetic and energetic metabolism of the follicle.

Since an important commercial interest lies in the nutritional value of nutritional supplements, a central question that arises is whether increasing the content of a seemingly adequate diet with specific amino acids, vitamins, and/or trace elements may further promote hair growth and quality. Pharmacy aisles and Internet drugstores are full of nutritional supplements promising full, thick, luscious hair for prices that range from suspiciously cheap to dishearteningly exorbitant. It would appear that, unless hair loss is due to a specific nutritional deficiency, there is only so much that nutritional therapies can do to enhance hair growth and quality.

Bahta et al.[2] originally cultured dermal hair papilla cells (DPCs) from both balding and nonbalding human scalps and demonstrated that balding DPCs grew slower in vitro than nonbalding DPCs. Loss of proliferative capacity of balding DPCs was associated with changes in cell morphology, expression of senescence-associated markers of oxidative stress as well as DNA damage, and decreased expression of markers of cell proliferation. This suggests that balding DPCs are particularly sensitive to environmental stressors such as cigarette smoke[3] and ultraviolet radiation (UVR).[4] These findings, along with the existing unmet needs in the management of androgenetic alopecia beyond the current evidence-based therapies,[5] suggest that further pathogenic pathways contributing to hair loss may be relevant and represent opportunities for further therapeutic strategies to include nutritional therapy.

Ingesting keratin does not help hair growth, as the protein cannot be broken down and absorbed. Therefore, constituent amino acids, from which the hair follicle can build up the keratin, need to be consumed. Cysteine is catabolized in the gastrointestinal tract and blood plasma, whereas cystine travels safely through the gastrointestinal tract and blood plasma and is promptly reduced to two cysteine molecules upon cell entry. Originally, the role of cystine in the production of wool was investigated starting in the 1960s, and it was found that enrichment of even what appeared to be a normal diet with the sulfur-containing amino acids cysteine and methionine increased wool production in sheep.[6],[7]

When considering which dietary supplements could be used for the improvement of hair growth in humans, L-cystine in combination with B-complex vitamins was, therefore, considered. Starting in the early 1990s, studies on the effect of dietary supplements containing L-cystine, medicinal yeast (a rich natural source of amino acids and B vitamins), thiamine (Vitamin B1), and pantothenic acid (Vitamin B5) were performed, showing improvement in the trichogram, in hair swelling as a criterion for hair quality, and in the tensile strength of the hair fiber.[8],[9] Eventually, Lengg et al.[10] performed the first double-blind, placebo-controlled study in women with telogen effluvium and demonstrated that the L-cystine, medicinal yeast, thiamine, and pantothenic acid-based dietary supplements increased and normalized the anagen hair rates within 6 months of treatment, while placebo did not. Combining with topical minoxidil in the treatment of androgenetic alopecia was predicted to add extra benefit, since it had previously been shown in whole hair follicle cultures that minoxidil not only increases the incorporation of thymidine as a marker of cell division but also leads to increased uptake of cysteine by the hair follicle.[11] This was underlined by the fact that regression analysis in the study performed by Lengg et al. showed that the presence of androgenetic alopecia in women with telogen effluvium did not negatively affect treatment efficacy.

In this issue, Gadzhigoroeva et al. finally provide the evidence for the superiority of a combination therapy of female androgenetic alopecia (FAGA) with a nutritional treatment (Panto[vi] gar®, Merz Pharmaceuticals GmbH, Frankfurt, Germany) and topical minoxidil over minoxidil monotherapy.

Topical minoxidil solution is the drug with the highest level of medical evidence and first-line treatment for FAGA, though its efficacy has limitations in terms of reducing hair loss or inducing new hair growth. The limited success rate of topical minoxidil for the treatment of FAGA means that further pathogenic pathways must be taken into account. Clinical and investigative advances have helped us to understand some of the pathogenic steps, leading to FAGA: besides genetic imbalance and peculiarities of sex hormone metabolism, additional pathogenic factors are suspected such as resident microbial flora, endogenous and exogenous stress, microinflammation, and others.[12]

An experiment performed on C57BL/6 mice, which developed hair loss when exposed to cigarette smoke, demonstrated that this effect could be prevented by the oral administration of N-acetylcysteine, an analog and precursor of cysteine and reduced glutathione, as well as cystine, the oxidized form of cysteine, in combination with Vitamin B6.[13] The effect was interpreted by the authors as to be possibly related to the glutathione-related detoxification system, an enzymatic antioxidant. Ultimately, the DPCs in androgenetic alopecia are understood to have a higher sensitivity to oxidative stress.[14]

Obviously, the hair, like the skin, is exposed to a variety of noxious environmental factors, of which UVR has been among the most studied in the skin. While the consequences of sustained UVR on unprotected skin are well appreciated, mainly aging and photocarcinogenesis, the effects of UVR on the hair are less understood. However, clinical and morphologic observations, as well as theoretical considerations, suggest that UVR does have some negative effects on hair growth.[4]

Finally, Hengl et al.[15] from Merz Pharmaceuticals GmbH, Frankfurt, Germany, provided the in vitro evidence that L-cystine and thiamine are essential for proliferation of normal human epidermal keratinocytes (NHEKs) under growth-limited conditions mimicking telogen effluvium and also exert an UVR-protective effect on growth-limited NHEKs in vitro as a model for environmental stress.

Hand in hand with the growing evidence for the modes of action and clinical efficacy of L-cystine and B Vitamin-based nutritional treatment for telogen effluvium, the results of the presented clinical study ultimately represent a proof of concept for the superiority of combination treatment versus monotherapy of FAGA.

References

1Groopman J. How doctors think. Boston, New York: Houghton Mifflin Company; 2007.
2Bahta AW, Farjo N, Farjo B, Philpott. MP Premature senescence of balding dermal papilla cells in vitro is associated with p16 (INK4a) expression. J Invest Dermatol 2008;128:1088-94.
3Trüeb RM. Association between smoking and hair loss: Another opportunity for health education against smoking? Dermatology 2003;206:189-91.
4Trüeb RM. Is androgenetic alopecia a photoaggravated dermatosis? Dermatology 2003;207:343-8.
5Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men-short version. J Eur Acad Dermatol Venereol 2018;32:11-22.
6Gillespie JM, Reis PJ. Dietary regulated biosynthesis of high-sulfur wool proteins. Bioche J 1966;98:669-77.
7Reis PJ, Tunks DA, Sharry LF. Plasma amino acid patterns in sheep receiving abomasal infusions of methionine and cystine. Aust J Biol Sci 1973;26:635-44.
8Petri H, Perchalla P, Tronnier H. Die Wirksamkeit einer medikamentösen Therapie bei Haarstrukturschäden und diffusen Effluvien – vergleichende Doppelblindstudie. Schweiz Rundsch Med Prax 1990;79:1457-62.
9Budde J, Tronnier H, Rahlfs VW, Frei-Kleiner S. Systemische therapie von diffusem Effluvium und Haarstrukturschäden. Hautarzt 1993;44:380-4.
10Lengg N, Heidecker B, Seifert B, Trüeb RM. Dietary supplement increases anagen hair rate in women with telogen effluvium: Results of a double-blind placebo-controlled trial. Therapy 2007;4:59-6.
11Buhl AE, Waldon DJ, Kawabe TT, Holland JM. Minoxidil stimulates mouse vibrissae follicles in organ culture. J Invest Dermatol 1989;92:315-20.
12Trüeb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol 2002;37:981-90.
13D'Agostini F, Fiallo P, Pennisi TM, De Flora S. Chemoprevention of smoke-induced alopecia in mice by oral administration of L-cystine and vitamin B6. J Dermatol Sci 2007;46:189-98.
14Upton JH, Hannen RF, Bahta AW, Farjo N, Farjo B, Philpott MP. Oxidative stress-associated senescence in dermal papilla cells of men with androgenetic alopecia. J Invest Dermatol 2015;135:1244-52.
15Hengl T, Herfert J, Soliman A, Schlinzig K, Trüeb RM, Abts HF. Cystine-thiamin-containing hair-growth formulation modulates the response to UV radiation in an in vitro model for growth-limiting conditions of human keratinocytes. J Photochem Photobiol B 2018;189:318-25.